The E3 Ubiquitin Ligase MDM2 Acts as a Key Determinant of Hepatic VLDL-triglycerides and Ketone Body Production in Obesity

Endocrine Abstracts
doi 10.1530/endoabs.41.gp132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer

PLoS ONE
Multidisciplinary
2015English

Functional Dissection of a HECT Ubiquitin E3 Ligase

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2007English

TRIAD1 Is Negatively Regulated by the MDM2 E3 Ligase

Oncology Reports
MedicineCancer ResearchOncology
2012English

Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets C-Myb for Nemo-Like Kinase (NLK)-induced Degradation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

A Role for the E3 Ubiquitin Ligase NEDD4 in Keloid Pathogenesis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

CHIP Is a U-Box-Dependent E3 Ubiquitin Ligase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

E3 Ubiquitin Ligase-Mediated Regulation of Bone Formation and Tumorigenesis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Synoviolin/Hrd1, an E3 Ubiquitin Ligase, as a Novel Pathogenic Factor for Arthropathy

Genes and Development
GeneticsDevelopmental Biology
2003English

Ubiquitin E3 Ligase MARCH7 Promotes Ovarian Tumor Growth

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy